[Federal Register Volume 71, Number 162 (Tuesday, August 22, 2006)]
[Notices]
[Page 48930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-13828]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (P.L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.
    Name: Clinical Laboratory Improvement Advisory Committee (CLIAC).
    Times and Dates: 8:30 a.m.-5 p.m., September 20, 2006. 8:30 a.m.-3 
p.m., September 21, 2006.
    Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th 
Street, NE., Atlanta, Georgia 30361, Telephone: (404) 892-6000.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This Committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the standards 
under which clinical laboratories are regulated; the impact on medical 
and laboratory practice of proposed revisions to the standards; and the 
modification of the standards to accommodate technological advances.
    Matters To Be Discussed: The agenda will include updates from the 
CDC, the Centers for Medicare & Medicaid Services, and the Food and 
Drug Administration; and presentations and discussion concerning the 
future of health laboratory practice including future directions in 
laboratory technology, interfaces between the laboratory and 
clinicians, and the future of the laboratory workforce. Agenda items 
are subject to change as priorities dictate.
    Providing Oral or Written Comments: It is the policy of CLIAC to 
accept written public comments and provide a brief period for oral 
public comments whenever possible. Oral Comments: In general, each 
individual or group requesting to make an oral presentation will be 
limited to a total time of five minutes (unless otherwise indicated). 
Speakers must also submit their comments in writing for inclusion in 
the meeting's Summary Report. To assure adequate time is scheduled for 
public comments, individuals or groups planning to make an oral 
presentation should, when possible, notify the contact person below at 
least one week prior to the meeting date. Written Comments: For 
individuals or groups unable to attend the meeting, CLIAC accepts 
written comments until the date of the meeting (unless otherwise 
stated). However, the comments should be received at least one week 
prior to the meeting date so that the comments may be made available to 
the Committee for their consideration and public distribution. Written 
comments, one hard copy with original signature, should be provided to 
the contact person below. Written comments will be included in the 
meeting's Summary Report.
    Contact Person for Additional Information: Devery Howerton, Acting 
Chief, Laboratory Practice Standards Branch, Division Public Health 
Partnerships--Laboratory Systems, National Center for Health Marketing, 
Coordinating Center for Health Information and Service, CDC, 1600 
Clifton Road, NE., Mailstop G-23, Atlanta, Georgia 30333; telephone 
(404) 718-1016; fax (404) 718-1080; or via e-mail at [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: August 15, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-13828 Filed 8-21-06; 8:45 am]
BILLING CODE 4163-18-P